| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Katharina Schregel, Caroline Baufeld, Miklos Palotai, Roberta Meroni, Paolo Fiorina, Jens Wuerfel, Ralph Sinkus, Yong-Zhi Zhang, Nathan McDannold, P Jason White, Charles R G Guttman. Targeted Blood Brain Barrier Opening With Focused Ultrasound Induces Focal Macrophage/Microglial Activation in Experimental Autoimmune Encephalomyelitis. Frontiers in neuroscience. vol 15. 2021-06-01. PMID:34054415. |
eae was induced in 12 6-8 weeks old female c57bl/6 mice using myelin oligodendrocyte glycoprotein (mog) peptide. |
2021-06-01 |
2023-08-13 |
mouse |
| Guozhong Ma, Jinzhao He, Yan Li, Yan Xu, Yunxin Hu, Fang Cu. Bilateral Meningo-Cortical Involvement in Anti-myelin Oligodendrocyte Glycoprotein-IgG Associated Disorders: A Case Report. Frontiers in neurology. vol 12. 2021-06-01. PMID:34054711. |
cortical t2-weighted fluid-attenuated inversion recovery (flair)-hyperintense lesions in anti-myelin oligodendrocyte glycoprotein (mog)-associated encephalitis with seizures (flames) are mostly unilateral and rarely spread to the bilateral cortex and meninges. |
2021-06-01 |
2023-08-13 |
Not clear |
| Douglas M Oswald, Julie Y Zhou, Mark B Jones, Brian A Cob. Disruption of hepatocyte Sialylation drives a T cell-dependent pro-inflammatory immune tone. Glycoconjugate journal. vol 37. issue 3. 2021-05-31. PMID:32222873. |
h-cko mice responded normally to innate and passively induced inflammation, but showed significantly increased morbidity in t cell-dependent house dust mite-antigen (hdm)-induced asthma and myelin oligodendrocyte glycoprotein (mog) peptide-induced experimental autoimmune encephalomyelitis (eae). |
2021-05-31 |
2023-08-13 |
mouse |
| Rachel E James, Renee Schalks, Eleanor Browne, Ioanna Eleftheriadou, Carmen Picon Munoz, Nicholas D Mazarakis, Richard Reynold. Persistent elevation of intrathecal pro-inflammatory cytokines leads to multiple sclerosis-like cortical demyelination and neurodegeneration. Acta neuropathologica communications. vol 8. issue 1. 2021-05-31. PMID:32398070. |
subpial demyelination was seen underlying these infiltrates, which was partly dependant on prior myelin oligodendrocyte glycoprotein (mog) immunisation. |
2021-05-31 |
2023-08-13 |
rat |
| Madhavi Tripathi, Arun Raj Sreedharan Thankarajan, Manjari Tripathi, Ajay Garg, Bhargavi Ramanujam, Snigdha, Chandrasekhar Ba. F-18 Fluorodeoxyglucose Positron Emission Tomography Metabolic Phenotype in Myelin Oligodendrocyte Glycoprotein Antibody-Positive Autoimmune Epilepsy. Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India. vol 36. issue 1. 2021-05-28. PMID:34040310. |
we describe the metabolic phenotype on f-18 fluorodeoxyglucose positron emission tomography (pet) in a 13-year-old female with myelin oligodendrocyte glycoprotein (mog) antibody-positive encephalitis. |
2021-05-28 |
2023-08-13 |
Not clear |
| Jong Hee Choi, Jinhee Oh, Min Jung Lee, Seong-Gyu Ko, Seung-Yeol Nah, Ik-Hyun Ch. Gintonin mitigates experimental autoimmune encephalomyelitis by stabilization of Nrf2 signaling via stimulation of lysophosphatidic acid receptors. Brain, behavior, and immunity. vol 93. 2021-05-27. PMID:33309911. |
we investigated the effect of gt in myelin oligodendrocyte glycoprotein (mog |
2021-05-27 |
2023-08-13 |
Not clear |
| Andrew J Kwilasz, Suzanne M Green Fulgham, Julissa Chante Duran-Malle, Anouk E W Schrama, Eric H Mitten, Laurel S Todd, Hardik P Patel, Tracey A Larson, Madison A Clements, Kevin M Harris, Scott T Litwiler, Lewis O Harvey, Steven F Maier, Raymond A Chavez, Kenner C Rice, Anne-Marie Van Dam, Linda R Watkin. Toll-like receptor 2 and 4 antagonism for the treatment of experimental autoimmune encephalomyelitis (EAE)-related pain. Brain, behavior, and immunity. vol 93. 2021-05-27. PMID:33358978. |
the current series of studies tested systemic tlr2/tlr4 antagonists in males and females in a low-dose myelin oligodendrocyte glycoprotein (mog) experimental autoimmune encephalomyelitis (eae) model, with reduced motor dysfunction to allow unconfounded testing of allodynia through 50+ days post-mog. |
2021-05-27 |
2023-08-13 |
Not clear |
| Pawan T Ojha, Vikram B Aglave, Girish Soni, Kamlesh A Jagiasi, Rakesh K Singh, Rakeshsingh Kamleshsingh Singh, Shashank Nagendr. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder. Neurology India. vol 68. issue 5. 2021-05-25. PMID:33109860. |
myelin oligodendrocyte glycoprotein (mog) antibody-associated cns demyelination: clinical spectrum and comparison with aquaporin-4 antibody positive neuromyelitis optica spectrum disorder. |
2021-05-25 |
2023-08-13 |
Not clear |
| Pawan T Ojha, Vikram B Aglave, Girish Soni, Kamlesh A Jagiasi, Rakesh K Singh, Rakeshsingh Kamleshsingh Singh, Shashank Nagendr. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder. Neurology India. vol 68. issue 5. 2021-05-25. PMID:33109860. |
the clinical phenotypes of myelin oligodendrocyte glycoprotein (mog) antibody disease, its disease course, and treatment are poorly understood and much work needs to be done towards this. |
2021-05-25 |
2023-08-13 |
Not clear |
| Xin Wang, Bin Li, Lan Liu, Li Zhang, Tianzhao Ma, Li Gu. Nicotinamide adenine dinucleotide treatment alleviates the symptoms of experimental autoimmune encephalomyelitis by activating autophagy and inhibiting the NLRP3 inflammasome. International immunopharmacology. vol 90. 2021-05-25. PMID:33290962. |
eae was induced in female c57bl/6 mice by immunization with myelin oligodendrocyte glycoprotein (mog) p35-55 and disease severity analyzed by neurological function score and histological scores of spinal cord sections stained with hematoxylin-eosin or luxol fast blue. |
2021-05-25 |
2023-08-13 |
mouse |
| Han Zhang, Yang Yang, Xiang Lu. Anti-MOG antibodies associated demyelination following encephalomeningitis: Case report. Journal of neuroimmunology. vol 353. 2021-05-25. PMID:33631487. |
myelin oligodendrocyte glycoprotein (mog) antibodies have been found in a broad range of demyelination diseases. |
2021-05-25 |
2023-08-13 |
Not clear |
| Amlan Kusum Datta, Adreesh Mukherjee, Biman Kanti Ray, Atanu Biswa. Anti-MOG antibody associated long segment myelitis presenting as anterior cord syndrome. BMJ case reports. vol 14. issue 5. 2021-05-21. PMID:34011662. |
investigations revealed serum anti-myelin oligodendrocyte glycoprotein (mog) antibody positivity. |
2021-05-21 |
2023-08-13 |
Not clear |
| Juichi Fujimori, Ichiro Nakashim. [Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease]. Brain and nerve = Shinkei kenkyu no shinpo. vol 73. issue 5. 2021-05-20. PMID:34006679. |
anti-myelin oligodendrocyte glycoprotein (mog) antibody-associated disease belongs to a new spectrum of disease entities that cause acute inflammatory demyelinating lesions in the central nervous system. |
2021-05-20 |
2023-08-13 |
Not clear |
| Masnon Nurul-Ain, Zuhratun Nazihah Khairul Kamal, Wan-Hazabbah Wan Hitam, Maimunah Abd Munaaim, Faizah Mohd Zak. Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series. Cureus. vol 13. issue 4. 2021-05-18. PMID:33996312. |
myelin oligodendrocyte glycoprotein (mog) optic neuritis: a case series. |
2021-05-18 |
2023-08-13 |
Not clear |
| Masnon Nurul-Ain, Zuhratun Nazihah Khairul Kamal, Wan-Hazabbah Wan Hitam, Maimunah Abd Munaaim, Faizah Mohd Zak. Myelin Oligodendrocyte Glycoprotein (MOG) Optic Neuritis: A Case Series. Cureus. vol 13. issue 4. 2021-05-18. PMID:33996312. |
myelin oligodendrocyte glycoprotein (mog) antibody disease has been recognised as a distinct demyelinating disorder. |
2021-05-18 |
2023-08-13 |
Not clear |
| Mathias Falck Schmidt, Gorm Pihl-Jensen, Margrethe Bastholm Bille, Jette Lautrup Frederikse. Anti-myelin oligodendrocyte glycoprotein antibodies in a girl with good recovery after five episodes of prior idiopathic optic neuritis. American journal of ophthalmology case reports. vol 22. 2021-05-18. PMID:33997466. |
to describe the clinical, radiological, immunological and electrophysiological features of a myelin oligodendrocyte glycoprotein (mog)-igg positive girl with five prior episodes of idiopathic bilateral optic neuritis (on). |
2021-05-18 |
2023-08-13 |
Not clear |
| Isidro Ferrer, Pol Andrés-Benito, Maria Victoria Zelaya, Maria Elena Erro Aguirre, Margarita Carmona, Karina Ausín, Mercedes Lachén-Montes, Joaquín Fernández-Irigoyen, Enrique Santamaría, José Antonio Del Ri. Familial globular glial tauopathy linked to MAPT mutations: molecular neuropathology and seeding capacity of a prototypical mixed neuronal and glial tauopathy. Acta neuropathologica. vol 139. issue 4. 2021-05-17. PMID:31907603. |
expression of oligodendrocyte markers olig1 and olig2mrna, and myelin-related genes mbp, plp1, cnp, mag, mal, mog, and mobp are significantly decreased in wm; cnpase, plp1, and mbp antibodies reveal reduction and disruption of myelinated fibres; and smi31 antibodies mark axonal damage in the wm. |
2021-05-17 |
2023-08-13 |
mouse |
| Anna S Tolmacheva, Kseniya S Aulova, Andrey E Urusov, Irina A Orlovskaya, Georgy A Nevinsk. Increase in Autoantibodies-Abzymes with Peroxidase and Oxidoreductase Activities in Experimental Autoimmune Encephalomyelitis Mice during the Development of EAE Pathology. Molecules (Basel, Switzerland). vol 26. issue 7. 2021-05-17. PMID:33916567. |
the exact mechanisms of multiple sclerosis (ms) development are still unknown, but the development of experimental autoimmune encephalomyelitis (eae) in c57bl/6 mice is associated with the violation of bone marrow hematopoietic stem cells (hscs) differentiation profiles associated with the production of harmful for human's autoantibodies hydrolyzing myelin basic protein, myelin oligodendrocyte glycoprotein (mog |
2021-05-17 |
2023-08-13 |
mouse |
| John S Tzartos, Katerina Karagiorgou, Dimitrios Tzanetakos, Marianthi Breza, Maria Eleftheria Evangelopoulos, Sygkliti-Henrietta Pelidou, Christos Bakirtzis, Ioannis Nikolaidis, Georgios Koutsis, Konstantinos Notas, Elisabeth Chroni, Ioannis Markakis, Nikolaos C Grigoriadis, Maria Anagnostouli, Anastasios Orologas, Dimitrios Parisis, Theodoros Karapanayiotides, Dimitra Papadimitriou, Vasiliki Kostadima, John Elloul, Iosif Xidakis, Thomas Maris, Paraskevi Zisimopoulou, Socrates Tzartos, Costas Kilidirea. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays. Journal of the neurological sciences. vol 410. 2021-05-14. PMID:31954354. |
igg antibodies to myelin oligodendrocyte glycoprotein (mog) detected by cell based assays (cba) have been identified in a constantly expanding spectrum of cns demyelinating disorders. |
2021-05-14 |
2023-08-13 |
Not clear |
| Takuya Ataka, Noriyuki Kimura, Etsuro Matsubar. A case of myelin oligodendrocyte glycoprotein-antibody-associated disease presenting with tumefactive demyelinating lesion. Multiple sclerosis and related disorders. vol 43. 2021-05-14. PMID:32474283. |
we report the case of a patient with myelin oligodendrocyte glycoprotein (mog)- antibody-associated disease presenting with tumefactive demyelinating lesion. |
2021-05-14 |
2023-08-13 |
Not clear |